Sort
48,018 grants matching “immunotherapy”
REGULATION OF ANTI-TUMOR IMMUNITY
$1,161,198Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2011 · CA
Innate lymphoid cell regulation of the host-microbiota interactions in cancer
$1,160,182Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Development of a potent and selective oral ENPP1 inhibitor for oncology
$1,160,011Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2022 · CA
The Boston Lung Cancer Survival Cohort
$1,159,880David C Christiani · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2025 · CA
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
$1,159,820Jonathan P Schneck · Johns Hopkins University · P41 · FY2023 · EB
A Vaccine for Schistosomiasis, "SchistoShield"
$1,159,786Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2016 · AI
Tumor selective inhibition of the WNT pathway
$1,159,628Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Unlocking evolutionarily latent immune functions for treating disease
$1,159,520Brenda L. Bass · University Of Utah · R01 · FY2022 · CA
Cytokines and T Cell Development
$1,158,724Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Immunotherapeutic Approaches for AIDS
$1,158,141George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
ANTIGEN SPECIFIC THERAPY IN CNS AUTOIMMUNE DISEASES
$1,158,119Brigham And Women'S Hospital · P01 · FY2001 · NS
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,158,050Elva M Arredondo · San Diego State University · U54 · FY2012 · CA
DRIVING NATURAL KILLER CELL IMMUNOTHERAPY IN THE CASTRATION-RESISTANT PROSTATE CANCER SETTING WITH NOVEL TRISPECIFIC KILLER ENGAGER MOLECULES
$1,157,718Regents Of The University Of Minnesota · · FY2020 · Defense Health Agency
Cell Prep Core
$1,157,471Steven Rosenberg · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Cell Production Facility Core
$1,157,471Mark Dudley · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION
$1,157,138Dana-Farber Cancer Institute · P01 · FY2001 · AI
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
$1,156,887Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Regulatory and effector T cells in oral immunotherapy for food allergy
$1,156,435Wayne G Shreffler · Massachusetts General Hospital · U19 · FY2013 · AI
Role of the microbiota in regulating the mononuclear phagocyte system
$1,156,319Romina Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$1,155,118Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2025 · CA
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,155,012Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens
$1,153,559Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2022 · AI
Induction of an Antitumor Immune Response in Patients with Melanoma
$1,153,528Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer
$1,152,921Joseph Patti · Agilvax, Inc. · R44 · FY2020 · CA
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
$1,152,838Bing Li · University Of Iowa · U01 · FY2023 · CA